Use of a Physiotherapy Assessment to Predict Extubation Failure in Mechanically Ventilated Patients: the EPIC Assessment
NCT ID: NCT06450678
Last Updated: 2024-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
330 participants
OBSERVATIONAL
2024-04-15
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Failed extubation is not without consequences, since it increases the risk of pneumopathy and mortality. It therefore seems essential to identify potential extubation failures using effective predictive criteria. Several of these predictive criteria have been studied separately in the literature, but are still not widely used in practice. Many studies have sought to identify these predictive criteria, without actually linking them. However, when combined in a single assessment prior to extubation, they could represent a reliable prediction and decision-making aid.
In the intensive care unit at Hôpital Bichat Claude Bernard, a team of physiotherapists dedicated solely to this unit carries out a routine EPIC Assessment, combining several criteria, some of which have individually demonstrated their reliability in predicting extubation outcome. Physiotherapists are health professionals working as part of the intensive care team, and are well versed in issues relating to bronchial congestion, respiratory function and muscle strength, whether for breathing or locomotion. Similarly, their involvement in issues relating to swallowing disorders acquired in intensive care gives them an overall view of the patient's ability to protect his or her airway post-extubation. The EPIC Assessment has been designed by them to address these issues. With the help of this assessment, and by following the cut-offs of the various criteria, they link the different criteria making up the EPIC Assessment and communicate a ""favorable"" or ""unfavorable"" opinion for extubation.
Our hypothesis is that the EPIC Assessment is, in addition to its interpretation by physiotherapists, a reliable tool for predicting the outcome of extubation."
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units
NCT05686850
Direct Extubation Versus Extubation After a Spontaneous Breathing Trial in Patients at Low Risk of Extubation Failure
NCT07019636
EXtubation With SUctioning or With Positive End-Expiratory Pressure in Intensive Care Unit
NCT05147636
Non-invasive Ventilation Following Extubation (Prophylactic) to Prevent Extubation Failure in Critically Obese Patients
NCT04014920
Instrumental Respiratory Physiotherapy in Difficult-to-wean ICU Patients
NCT06499389
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The spontaneous ventilation test will be carried out in the T-Tube, on the basis of a medical decision and within the framework of care, if the patients meet the weaning conditions:
* No sedation
* No inotropes or vasopressors
* Consistent response to simple commands
* FiO2 \< 50%
* PEEP \< 5 cmH2O
The criteria for a successful T-Tube test are:
* FR \< 35 cycles/min
* SpO2 \> 90%,
* Variation of less than 20% in FR or systolic blood pressure,
* No sweating, agitation or vigilance disorders.
Inclusion of patients by investigators after a successful spontaneous ventilation test.
Data will be collected describing the characteristics of patients on the day of their T-Tube test, and will also list the various risk factors for extubation failure already known in the literature, in order to avoid confounding bias
EPIC Assessment by physiotherapists: Within 30 minutes of a successful spontaneous ventilation test, the physiotherapists are called in by the nursing team to carry out the EPIC Assessment. This assessment takes the form of a table containing the following criteria:
* Glasgow Coma Scale (GCS): X \< 11 ≤ O
* Rapid Shallow Breathing Index (RSBI): X ≤ 75 \< O
* Maximum Inspiratory Pressure (MIP): X \< l-25l \< O
* Peak Expiratory Flow (PEF): X \< l-60l \< O
* Bronchial congestion: X = "++" and "+++"; O = "+" and "Ø"
* Salivary stasis: X = "++" and "+++"; O = "+" and "Ø".
* Orofacial motricity: X = Incomplete and O = Complete
* Cervical spine flexion: X = Impossible and O = Possible
* Nausea reflex: X = Absent and O = Present on at least one side.
* Medical Research Council (MRC): X \< 36 and O \> 36.
The patient is placed in a semi-sitting position, having been lifted into bed beforehand.
The physiotherapist first takes information about the starting conditions, then decreases the Inspiratory Pressure (IP) to 7 and the Positive Expiratory Pressure (PEP) to 0.
Each criterion is then assessed by the physiotherapist with the patient's participation. The cut-offs described in the literature are taken into account to validate each criterion: an "X" sign predicts extubation failure, an "O" sign predicts extubation success.
Inter-rater reproducibility study: the EPIC grids will be reviewed at the end of the research by a physiotherapist who has not carried out this EPIC, who will be responsible for giving a "favorable" or "unfavorable" opinion based on the results of the EPIC assessment (opinion not taken into account for the extubation decision - for reproducibility analysis only).
Binary global assessment: "favorable" or "unfavorable" opinion, issued collectively by the entire team in charge of the patient (physiotherapist, senior doctor, junior doctor (intern), state-registered nurse, nursing auxiliary).
Extubation decision: taken by the doctor after the spontaneous ventilation test and communication by the physiotherapists of their favorable or unfavorable opinion. Participation in the research will not affect patient management. A patient who has not been extubated will be reassessed according to the care plan in the following days (new spontaneous ventilation test, new EPIC assessment).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adult patients with mechanical ventilation
Adult patients admitted to intensive care with mechanical ventilation for more than 48 hours
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to intensive care and placed on invasive mechanical ventilation for more than 48 hours
* Having passed a T-Tube spontaneous ventilation test \< 24h
Exclusion Criteria
* Severe psychiatric pathology or cognitive disorders
* Uncooperative patient
* Patient under therapeutic restriction (terminal extubation)
* Patient who has already participated in research
* Patient or close relative (if patient not able) opposed to research
* No relative if patient unable to receive information
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antoine SHENOUDA
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bichat - Claude Bernard Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01734-41
Identifier Type: OTHER
Identifier Source: secondary_id
APHP231743
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.